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Aim. To investigate an effect of the Focal adhesion kinase 1 (FAK1) expression on the level of tyrosine phos-
phorylation of an adaptor protein SHB and to find functional consequences of this posttranslational modifica-
tion. Methods. Recombinant DNA construction, protein expression and purification, human cell transfection, 
western blot. Results. Expression of FAK1 induces massive tyrosine phosphorylation of SHB adaptor and 
enhances its interaction in vitro with SH2 domains of a range of the signaling proteins such as PI3K, ABL, 
CRK and PLCG1. Additionally we have found that Epstein-Barr virus protein LMP2A can partially mimic the 
FAK1-mediated effect strongly elevating the efficiency and SHB interaction with the above-mentioned pro-
teins. While the expression of individual proteins elevated SHB phosphorylation level, the co-expression of 
LMP2A and FAK1 did not display a synergetic effect. Conclusions. FAK1 as well as LMP2A induce SHB 
tyrosine phosphorylation and enhance its interaction with a set of the signaling proteins. 
K e y w o r d s: FAK1, SHB, LMP2A, phosphorylation.
Introduction
Focal adhesion kinase 1 (FAK1) is an ubiquitously 
expressed non-receptor tyrosine kinase which is lo-
calized to focal adhesion where a cell is attached to 
the extracellular matrix. FAK1 operates downstream 
of the cell surface receptors, such as integrins and 
receptor tyrosine kinases i.e. EGFR, PDGFR, 
G-protein coupled receptors (GPCR), EPHA2, ne-
trin receptors and LDL receptors [1,2]. Upon incom-
ing activation signal from the above mentioned re-
ceptors FAK1 associates with kinase Src, gets phos-
phorylated by latter and autophosphorylated to gain 
the maximum of intrinsic kinase activity. Activated 
FAK1 phosphorylates ACTN1, ARHGEF7, GRB7, 
RET, WASL and promotes phosphorylation of 
BCAR1, GIT2 and SHC1, many of these proteins 
are crucial regulators of the cytoskeleton reorganiza-
tion, cell spreading, migration, cell cycle progres-
sion, and prevention of apoptosis [3-5]. FAK1 is 
comprised of a centrally located kinase domain 
flanked by the large N- and C-terminal non-catalytic 
domains (Fig. 1). 
The N-terminal region of FAK1 contains FERM 
homology domain, whereas the C-terminal region 
of FAK1 contains two proline-rich motifs and a fo-
cal adhesion targeting (FAT) domain that mediates 
its discrete localization to focal adhesions upon 
FAK1 activation [6]. In addition to the function as 
a kinase, FAK1 also serves as a scaffolding protein. 
FAK1 contains th e binding sites for many signal-
ing proteins (Fig.1). FAK1 was shown to interact 
with EGFR, PDGFR, Src, Shc, phosphotidylinosi-
tol 3-kinase (PI3K), and phospholipase Cg1 (PLC 
g1), signaling adaptors GRB2 and GRB7, paxillin, 
tallin [1, 4, 7]. 
FAK1 interacts with and gets activated by signal-
ing scaffold SHB[8]. FAK1 and SHB in a concert 
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regulate the cell spreading and migration [8]. SHB 
is an ubiquitously expressed protein of about 56 kDa 
comprising N-terminal proline-rich domain (PRD) 
which interacts with SH3 domain of PI3K, phos-
photyrosin-binding domain (PTB) and C-terminally 
located SH2 domain that binds the platelet derived 
growth factor receptor (PDGFR) and IL-2 receptor 
and T-cell receptor [8]. Recently SHB was shown to 
modulate the FAK1 signaling activity in ABL-BCR 
lymphoproliferative disorder [9]. SHB operates 
downstream of plasma membrane receptor kinases 
and participates in AKT/PI3K signaling pathway 
[10, 11].
Here we show that FAK1 can regulate interaction 
of SHB scaffold with a range of SH2 domain con-
taining signaling molecules such as CRK, PI3K and 
с-ABL through the tyrosine phosphorylation of 
SHB. It has been found that expression of viral pro-
tein LMP2A can partially mimic the effect of FAK1 
overexpression enhancing binding of SHB to the 
SH2-domains of CRK, PI3K, GRB2, PLC g1 and 
с-ABL. An intriguing observation appeared that 
FAK1 can partially block LMP2A-induced phos-
phorylation of SHB. 
Material and Methods
Antibodies and plasmids
Monoclonal antibody to the FLAG epitope (clone 
M2) was from Sigma; monoclonal α-omni (D-8) and 
α-pTyr (pY99) antibodies were from Santa Cruz 
Biotechnology; a monoclonal α-HA (MMS-101P) 
antibody was from Covance. 
Flag-LMP2A and omni-SHB-HA encoding plas-
mids were described previously [12]. The plasmids 
encoding GST-fused SH2 domains of PLCG1, PI3K, 
ABL, GRB2 and CRK were described before [13]. 
The plasmid encoding HA-FAK1 was kindly 
provided by Dr. V. M. Golubovskaya [14]. 
Cell culture and transfection
293 cells were maintained in Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with 10% 
fetal bovine serum, 50 U/ml penicillin and 100 μg/ml 
streptomycin. The cells were transiently transfected 
using JetPEI (Polyplus Transfection) according to the 
manufacturer’s instructions and processed 24h after 
transfection. 
Immunoprecipitation
Cell lysis and immunoprecipitation were performed 
as described previously [15].
Proteins expression, purification and GST-pull 
down assay
GST-fused SH2-domains of PLCG1, PI3K, ABL, 
GRB2 and CRK were expressed in E.coli BL21 DE3 
and affinity purified using glutathione-sepharose 4B 
(GE Healthcare) according to the manufacturer’s in-
structions and further used for the 
GST-pull down assays as described before [13]. 
Results and Discussion
Taking into consideration the fact that SHB regu-
lates the FAK1 [8] activity through its tyrosine phos-
phorylation we asked whether there is a reciprocal 
loop of SHB regulation by FAK1. At first we per-
formed in silico prediction of the FAK1 capability to 
phosphorylate SHB undertaken by means of GPS3.0 
Fig. 1. A schematic representation of FAK1 and SHB proteins. 
The most important phosphotyrosine sites of FAK1 are shown 
above with indication of proteins which recognize them. FAK1-C 
term lacking N-terminal portion with kinase domain is demon-
strated below the full-length one. SHB comprises the proline-rich 
domain (PRD), phosphotyrosine-binding domain (PTB) and SH2 
domain, the two latter domains of SHB are hosphotyrosine-recog-
nition modules. The tyrosine residues predicted by GPS3.0 to be 
phosphorylated by FAK1 are show above SHB scheme. 
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software (Group-based Prediction System) [16]. 
According to this analysis 8 tyrosine residues were 
predicted to be phosphorylated by FAK1 at high 
stringency, namely Y96, Y162, Y178 Y246, Y272, 
Y297, Y336, Y444 (Fig.2A). So, we took advantage 
of the experimental data from PhosphoSitePlus data-
base (http://www.phosphosite.org/) and found that 5 
tyrosine residues (namely Y96, Y246, Y272, Y297, 
Y336) out of 8 predicted ones were found to be 
phosphorylated in human and mouse samples. 
Moreover, the indicated five tyrosine residues are 
conserved in Vertebrates in contrast to tyrosines at 
the positions Y162, Y178, Y444 (Fig. 2A) To test 
experimentally the hypothesis that FAK1 may phos-
phorylate SHB we co-expressed the full-length HA-
tagged FAK1 or its truncated omni-tagged FAK1-
Cterm lacking kinase domain (see Fig. 1) together 
with omni-tagged SHB in 293 cells. The basal level 
of SHB phosphorylation in 293 cells was below of 
the detection limit. Despite the equal amount of pre-
cipitated SHB (Fig.2B, second panel), a level of its 
phosphorylation is greatly increased in the cells 
transfected with full-length FAK1 but not in the cells 
with expression of FAK1-Cterm lacking a kinase do-
main (Fig.2B, first panel). 
Next, we asked whether the FAK1-induced phos-
phorylation of SHB has a functional consequence. 
It’s widely accepted that phosphorylation in general 
serves to switch proteins conformations or to create 
interaction interfaces which can be recognized by 
the specialized phospho-binding protein domains. 
One of the well-known class of phosphotyrosine rec-
ognition modules is SH2-domain (Src homology2), 
which specifically binds the phosphotyrosine resi-
dues [17]. Some of the established SHB binding sub-
strates such as GRB2, ABL, PLCg1 contain SH2-
domain [18]. We studied whether the FAK1-induced 
phosphorylation of SHB can modulate its interaction 
with SH2 domains of the binding partners. To do so, 
we used a set of GST-fused SH2-domains as a bait in 
pull-down assay to precipitate SHB from the cell ex-
tracts transfected with HA-FAK1. As Fig. 3A shows 
the overexpression of FAK1 enhanced the interac-
tion of SHB with SH2 domains of CRK, PI3K and 
ABL while no interaction with SH2 domain of GRB2 
was detected. This fact may evidence that the FAK1-
dependent SHB phosphorylation specifically trig-
gers the association of different SH2 domains con-
taining signaling proteins with SHB. Additionally, 
Fig.2. Overexpression of FAK1 kinase induces tyrosine phos-
phorylation of SHB protein. A. Table representing a list of phos-
photyrosine sites of SHB predicted with highest stringency by 
GPS3.0 to be phosphorylated by FAK1 kinase. Category “mam-
mals” contains Homo sapiens, Mus musculus, Rattus norvegicus, 
Canis lupus. B. 293 cells were co-transfected with omni-SHB-
HA, HA-FAK1 or omni-FAK1-Cterm. 24h after transfection cells 
were harvested, lysed and omni-SHB-HA immunoprecipitated 
with monoclonal a-omni antibodies from the respective cell ex-
tracts. Precipitated material was analyzed by western blot: tyro-
sine phosphorylated species were detected by monoclonal a-phos-
photyrosine antibody, total omni-SHB-HA was visualized by a-
omni antibody. Two lower panel show immunodetection of omni-
SHB-HA, full-length and omni-FAK1-Cterm in cell extracts. 
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the interaction of SHB with SH2 domain of PLCg1 
was significantly increased upon the FAK1 overex-
pression but the binding of PLCg1 SH3 domain to 
SHB was decreased suggesting that the tyrosine 
phosphorylation of SHB can regulate binding prop-
erties of its proline-rich sequences (Fig.3A, 
lanes 9, 10).
The interaction of SHB with PI3K that is mediated 
by SH2 domains of latter is of great interest as SHB 
is required for the activation of the PI3K/AKT path-
way [11] and the regulation of cell survival [18]. ABL 
is a proto-oncogene that encodes a protein tyrosine 
kinase involved in a variety of cellular processes, in-
cluding cell division, adhesion, differentiation, and 
response to stress. In the signaling pathways ABL is 
located upstream of PI3K/AKT [19]. A functional 
significance of phosphorylation-dependent interac-
tion with ABL kinase is enigmatic but recently SHB 
has been shown to enhance FAK1 activity in the 
BCR-ABL aberrant cells that caused accelerated dis-
ease progression emphasizing the importance of 
ABL/SHB interplay [9]. It was demonstrated that the 
interactions between SHB and ABL regulates the 
ABL kinase activity. The data suggest that ABL binds 
to tyrosine phosphorylated SHB via a concerted ef-
fort involving both ABL SH3- and SH2-domains and 
these interactions modulate cell death in response to 
the genotoxic agents [20]. In general the place of 
SHB in signaling network is depicted at the Fig. 3D. 
The activated receptor tyrosine kinases transduce a 
Fig.3. FAK1 and LMP2A regulate association of SHB with SH2-domains. A. Bacterially expressed GST-fused SH2 (A, B and C) or 
SH3-PLCg1 (A, lanes 9 and 10) of indicated proteins were immobilized on glutathione-beads and incubated with 293 lysates co-
transfected with omni-SHB-HA and HA-FAK1 (A and B) or Flag-LMP2A (C) or vector. D. Schematic representation of SHB role in 
RTKs- and integrin-driven signaling. SHB may directly interact with depicted proteins, with red dashed arrow is shown newly dis-
covered phosphorylation event, FAK1-induced interactions are shown with bold back arrows. Indirect effects are shown with dashed 
arrows. WCE stands for the whole cell extract.
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signal to ABL, SRC, phospholipase C and PI3K that 
results in the cell proliferation or survival depending 
on the signaling context. SHB is required for the sig-
naling downstream of RTKs and its role depends on 
the interaction with the protein-partners such as ABL, 
SRC, GRB2, PI3K and PLCg1. FAK1 is activated by 
integrins (Fig. 3D) and indirectly by RTKs signaling 
that leads to the cytoskeleton changes and cell migra-
tion [18]. We suggest that the FAK1-induced SHB 
phosphorylation may be a part of signaling cross-talk 
between RTKs- and integrin-controlled pathways. 
Additionally, the augmentation of FAK activity in 
human tumors, in which it is often overexpressed, oc-
curs through its elevated expression [1], so described 
here the FAK1-induced effects may be a part of path-
ological phenotype, e.g. the resistance to apoptosis 
and invasiveness. 
Previously we have shown that the expression of 
viral protein LMP2A induces the tyrosine phosphor-
ylation of SHB [12]. To address whether the LMP2A-
induced phosphorylation of SHB may have an im-
pact on the SHB binding to the SH2-domain con-
taining proteins we applied a before mentioned ap-
proach. As Fig. 3B shows the expression LMP2A 
strongly enhanced the binding of SHB to a range of 
the SH2 domains of such proteins as CRK, GRB2, 
PI3K, PLCg1 and ABL. One can suggest that FAK1 
and LMP2A caused the phosphorylation of non-
overlapping sets of tyrosine residues as far as the 
LMP2A expression enhanced the SHB association 
with GRB2 but for FAK1 (Fig3 A and B). The de-
scribed effects of LMP2A and FAK1 expression on 
the SHB in vitro interaction with before mentioned 
SH2 and SH3 domains could be explained in two 
ways: 1) both FAK1 and LMP2A cause the SHB 
phosphorylation at certain sites that are recognized 
by respective SH2 domains or 2) FAK1 and LMP2A 
serve as a scaffold to bring together SHB and before 
mentioned domains. The later statement is supported 
by our unpublished observation that LMP2A and 
FAK1 can interact with SH2-domains of PI3K, ABL 
and GRB2. From the other hand, the fact that FAK1 
negatively regulated SHB binding to the SH3-
domain of PLCg1 challenges the idea that FAK1 
serves simply as an adaptor. Unfortunately, so far it 
is difficult to uncouple the phosphorylation-induced 
and potential scaffolding effects of FAK1 on the 
SHB interaction with its partners. 
As far as the expression of both LMP2A and 
FAK1 strongly upregulated the SHB tyrosine phos-
phorylation we expected to detect a synergetic effect 
of co-expression of both proteins with SHB. In addi-
tion while the expression of individual proteins ele-
vated SHB phosphorylation level, the co-expression 
of LMP2A and FAK1 had remarkable negative co-
operation effect (Fig.4). The reason for this kind of 
conclusion is the fact that the most robust effect on 
the SHB phosphorylation was caused by LMP2A 
while the co-expression of FAK1 decreased this ef-
fect to the FAK1-induced level. One could suggest 
that FAK1 partially inhibits the activity of Syk and 
Lyn tyrosine kinases which carry out the LMP2A-
induced SHB phosphorylation [12]. 
SHB is required for the tonic and serum-indepen-
dent AKT activation caused by Epstein-Barr virus 
Fig.4. Expression of FAK1 and LMP2A displays negative coop-
eration effect on the tyrosine phosphorylation levels of SHB. 
293 cells were co-transfected with omni-SHB-HA, HA-
FAK1+control vector or HA-FAK1 and Flag-LMP2A. Levels of 
SHB tyrosine phosphorylation were estimated as described at 
figure 2B.
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protein LMP2A [10] and in line with this observa-
tion it has been shown that LMP2A induces the SHB 
tyrosine phosphorylation [12]. We suggest that de-
scribed here LMP2A-induced interaction of SHB 
with SH2 domains of PI3K, ABL, PLCg1 may be 
responsible for the downstream signaling towards 
AKT and RAS activation. Moreover, it has been 
shown that LMP2A induces the epithelial cell migra-
tion [21] in FAK1-dependent manner [22]. We as-
sume that signaling downstream of FAK1 and 
LMP2A may converge on SHB. The fact that LMP2A 
can induce the SHB phosphorylation that triggers 
SHB binding to GRB2, PLCG1, PI3K and other pro-
teins in this way mimicking the FAK1 activity may 
represent an important aspect of the LMP2A-induced 
pathogenicity providing a link between the LMP2A-
driven SHB activation and cell migration. 
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Кіназа фокальної адгезії (FAK1) регулює 
фосфорилювання адаптерного білка SHB та його 
взаємодію з низкою сигнальних білків.
О. В. Дергай, А. М. Яручик, А. В. Риндич
Мета. Дослідити ефект надексперсії кінази фокальної адгезії 
(FAK1) на рівнь фосфорилювання залишків тирозину адаптор-
ного білка SHB та знайти функціональне значення цієї пост-
трансляційної модифікації. Методи. Конструювання рекомбі-
нантних ДНК, експресія та очистка рекомбінантних білків, 
трасфекція клітинних ліній, вестерн блот. Результати. 
Надексперсія FAK1 в клітинах лінії 293 викликає масивне фос-
форилювання залишків тирозину адапторного білка SHB та 
значно підсилює його взаємодію in vitro з SH2-доменами низки 
сигнальних білків, таких як PI3K, ABL, CRK та PLCg1. Крім 
того, білок LMP2A вірусу Епштейна-Барр може посилювати in 
vitro зв’язування SHB з вищезазначеними білками, так само, як 
і FAK1. Тоді як надекспресія окремих білків FAK1 та LMP2A 
підвищувала рівні фосфорилювання SHB, їх ко-експерсія не 
мала синергічного ефекту. Висновки. Експресія FAK1 та 
LMP2A індукує фосфорилювання залишків тирозину адаптор-
ного білка SHB та підсилює його взаємодію з SH2-доменами 
низки сигнальних білків.
К л юч ов і  с л ов а: FAK1, SHB, LMP2A, фосфорилювання.
Киназа фокальной адгезии (FAK1) регулирует 
фосфорилирование адаптерного белка SHB и его 
взаимодействие с рядом сигнальных белков.
А. В. Дергай,  А. М.  Яручик, А. В. Рындич
Цель. Исследовать эффект суперэкспрессии киназы фокаль-
ной адгезии (FAK1) на уровень фосфорилирования остатков 
тирозина адаптерного белка SHB и найти функциональное зна-
чение этой посттрансляционной модификации. Методы. 
Конструирование рекомбинантных ДНК, экспрессия и очистка 
рекомбинантных белков, трансфекция клеточных линий, ве-
стерн блот. Результаты. Суперэксперссия FAK1 в клетках ли-
нии 293 приводит к многократному повышению уровней фос-
форилирования остатков тирозина адаптерного белка SHB, что 
в свою очередь приводит к усилению взаимодейсвия с SH2-
доменами ряда сигнальных белков, таких как PI3K, ABL, CRK 
та PLCg1. Кроме того, белок LMP2A вируса Эпштейна-Барр 
может усиливать in vitro взаимодействие SHB с указанными 
белками, аналогично FAK1. Тогда как суперэкспрессия отдель-
ных белков FAK1 та LMP2A приводила к интенсификации 
фосфорилирования SHB, их ко-экспрессия не обладала синер-
гическим эффектом. Выводы. Экспрессия FAK1 и LMP2A ин-
дуцирует фософрилирование остатков тирозина адаптерного 
белка SHB и усиливает его взаимодействие с SH2-доменами 
ряда сигнальных белков.
К л юч е в ы е  с л ов а: FAK1, SHB, LMP2A, фосфорилирова-
ние.
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